4 ms·
It occurs to me that they could have followed the software trend where everything is a subscription service. As more is learned from the genome, they can delive
by Eric_WVGG 7y ago
It occurs to me that they could have followed the software trend where everything is a subscription service. As more is learned from the genome, they can deliver more value to the customers over time.
- dougmwne 7y agoYeah, it seems like a major mistake to sell this as a one-time purchase. Market it as "genetic monitoring" Charge a monthly or yearly fee to keep getting new genetic insights as research discovers the function of more mutations. Offer upsell re-tests with more complete or accurate sequencing. I think they must have been banking on the data-set itself being highly valuable and made the tests cheap, then ran out of customers on both ends of the equation.
- joejerryronnie 7y agoGMAAS
- jakebol 7y agothey already provide this as a service
- cnst 7y agoI believe they actually did have it as a subscription model at one point (I think it was at a time that it was a choice of either $400 one-time, or $99 for the kit + extra for the subscription), but I guess they have more competition now, plus it's cheaper?